Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
WuXi AppTec
Pharma
AstraZeneca, GSK, Takeda—Fierce Pharma Asia
AZ executives past and present are under investigation in China. GSK obtained a T-cell engager for lupus. Takeda hit a orexin setback. And more.
Angus Liu
Nov 1, 2024 8:20am
Breaking down BIOSECURE—Industry implications, what comes next
Oct 4, 2024 9:13am
Regor, Legend, WuXi—Fierce Pharma Asia
Oct 4, 2024 8:20am
WuXi service providers eye asset sales amid BIOSECURE threat: FT
Oct 3, 2024 9:47am
CDMO industry projects growth, spurns BIOSECURE: CPHI research
Sep 30, 2024 10:42am
Akeso-Summit, BIOSECURE, Candid and more—Fierce Pharma Asia
Sep 13, 2024 8:53am
